Abstract
The herpes simplex virus transactivator VP16 par-ticipates in the formation of a multiprotein-DNA complex with the ubiquitous octamer-motif-binding factor Oct-1. Complex formation is dependent on specific amino acids in the Oct-1 homoeodomain which are in positions analogous to positive control mutations in helix 2 of the λ phage repressor helix-turn-helix motif, indicating that this structure is an ancient target for protein-protein interactions mediating transcriptional control.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Van Dyke, M. W., Roeder, R. G. & Sawadogo, M. Science 241, 1335–1338 (1988).
Buratowski, S., Hahn, S., Guarente, L. & Sharp, P. A. Cell 56, 549–561 (1989).
Ptashne, M. Nature 335, 683–689 (1988).
Ptashne, M. et al. Cell 19, 1–11 (1980).
Hochschild, A., Irwin, N. & Ptashne, M. Cell 32, 319–325 (1983).
Hawley, D. K. & McClure, W. R. Cell 32, 327–333 (1983).
McKnight, J. L. C., Kristie, T. M. & Roizman, B. Proc. natn. Acad. Sci U.S.A. 84, 7061–7065 (1987).
Preston, C. M., Frame, M. C. & Campbell, M. E. M. Cell 52, 425–434 (1988).
O'Hare, P. & Goding, C. R. Cell 52, 435–445 (1988).
Gerster, T. & Roeder, R. G. Proc. natn. Acad. Sci. U.S.A. 85, 6347–6351 (1988).
Batterson, W. & Roizman, B. J. Virol. 46, 371–377 (1983).
Campbell, M. E. M., Palfreyman, J. W. & Preston, C. M. J. molec. Biol. 180, 1–19 (1984).
Mackem, S. & Roizman, B. Proc. natn. Acad. Sci. U.S.A. 79, 4917–4921 (1982).
Preston, C. M., Cordingley, M. G. & Stow, N. D. J. Virol. 50, 708–716 (1984).
Baumruker, T., Sturm, R. & Herr, W. Genes Dev. 2, 1400–1413 (1988).
ApRhys, C. M. J., Ciufo, D. M., O'Neill, E. A., Kelly, T. J. & Hayward, G. S. J. Virol. 63, 2798–2812 (1989).
Herr, W. et al. Genes Dev. 2, 1513–1516 (1988).
Sturm, R. A. & Herr, W. Nature 336, 601–604 (1988).
Tanaka, M., Grossniklaus, U., Herr, W. & Hernandez, N. Genes Dev. 2, 1764–1778 (1988).
Schaffner, W. Trends Genet. 5, 37–39 (1989).
Triezenberg, S. J., Kingsbury, R. C. & McKnight, S. L. Genes Dev. 2, 718–729 (1988).
Hope, I. A. & Struhl, K. Cell 46, 885–894 (1986).
Ma, J. & Ptashne, M. Cell 48, 847–853 (1987).
Hope, I. A., Mahadevan, S. & Struhl, K. Nature 333, 635–640 (1988).
Laughon, A. & Scott, M. P. Nature 310, 25–31 (1984).
Shepherd, J. C. W., McGinnis, W., Carrasco, A. E., Robertis, E. M. D. & Gehring, W. J. Nature 310, 70–71 (1984).
Scott, M. P., Tamkun, J. W. & Hartzell III, G. W. BBA Reviews on Cancer (in the press).
Garcia-Blanco, M. A., Clerc, R. G. & Sharp, P. A. Genes Dev. 3, 739–745 (1989).
Otting, G. et al. EMBO J. 7, 4305–4309 (1988).
Jordon, S. R. & Pabo, C. O. Science 242, 893–899 (1988).
Aggarwal, A. K., Rodgers, D. W., Drottar, M., Ptashne, M. & Harrison, S. C. Science 242, 899–907 (1988).
Sturm, R. A., Das, G. & Herr, W. Genes Dev. 2, 1582–1599 (1988).
McLean, C. et al. J. gen. Virol. 63, 297–305 (1982).
Fletcher, C., Heintz, N. & Roeder, R. G. Cell 51, 773–781 (1987).
Clerc, R. G., Corcoran, L. M., LeBowitz, J. H., Baltimore, D. & Sharp, P. A. Genes Dev. 2, 1570–1581 (1988).
Finney, M., Ruvkun, G. & Horvitz, H. R. Cell 55, 757–769 (1988).
Bodner, M. et al. Cell 55, 505–518 (1988).
Ingraham, H. A. et al. Cell 55, 519–529 (1988).
Nelson, C., Albert, V. R., Elsholtz, H. P., Lu, L. I.-W. & Rosenfeld, M. G. Science 239, 1400–1405 (1988).
LaBella, F., Sive, H. L., Roeder, R. G. & Heintz, N. Genes Dev. 2, 32–39 (1988).
Desplan, C., Theis, J. O'Farrell, P. H. Cell 54, 1081–1090 (1988).
Hoey, T. & Levine, M. Nature 332, 858–861 (1988).
Muller, M. M., Ruppert, S., Schaffner, W. & Matthias, P. Nature 336, 544–551 (1988).
Scheidereit, C., Cromlish, J. A., Gerster, T., Kawakami, K., Balmaceda, C.-G., Currie, R. A. & Roeder, R. G. Nature 336, 551–557 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stern, S., Tanaka, M. & Herr, W. The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature 341, 624–630 (1989). https://doi.org/10.1038/341624a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/341624a0
This article is cited by
-
Regulation of host and virus genes by neuronal miR-138 favours herpes simplex virus 1 latency
Nature Microbiology (2021)
-
Structure and VP16 binding of the Mediator Med25 activator interaction domain
Nature Structural & Molecular Biology (2011)
-
HSV trafficking and development of gene therapy vectors with applications in the nervous system
Gene Therapy (2005)
-
Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers
Gene Therapy (2001)
-
HSV-1-Based Vectors for Gene Therapy of Neurological Diseases and Brain Tumors: Part I. HSV-1 Structure, Replication and Pathogenesis
Neoplasia (1999)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.